BOSTON (TheStreet) -- Ready for some fun? Here are the nominees for Worst Biotech CEO of 2014:
Marc Beer of Aegerion Pharmaceuticals (AEGR) , John Johnson of Dendreon (DNDN) , co-nominees Steve Kriegsman of CytRx (CYTR) and Mark Ahn of Galena Biopharma (GALE) , Joe Podolski of Repros Theraeutics (RPRX) , Linda Powers of Northwest Biotherapeutics (NWBO) , and last but not least, Martin Shkreli of Retrophin (RTRX) .
Must Read: Warren Buffett's Top 10 Dividend Stocks
These seven nominees are competing for the dishonor of holding the Nance Trophy, named after David Nance, the former CEO of now bankrupt and defunct Introgen Therapeutics. Few CEOs in biotech did more to hone the fine craft of investor bamboozlement and outright incompetence as Introgen's Nance. Last year's winner (loser) was Vical's (VICL) Vijay Samant.
Please read the nominating summaries and vote for your favorite -- or least favorite -- candidate in the interactive poll at the end of the story. I'll tally your votes and award the trophy at the end of the week.
Marc Beer, Aegerion Pharmaceuticals
Marc Beer is not a Worst Biotech CEO nominee for allegedly snorting cocaine, drinking booze and having sex with the wife of his investment banker (while the investment banker watched, allegedly, of course.) Dude, we've all been there. You get a pass on that.